Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Processing


Boehringer Ingelheim biopharma head joins Merck, plus EMA, Shire, EFPIA

By Fiona BARRY , 24-Feb-2014
Last updated on 24-Feb-2014 at 12:50 GMT

Simon Sturge leaves Boehringer Ingelheim to head Merck's biosimilars unit, as well as the European Medicines Agency, Shire and EFPIA in this week's People on the Move column.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

All Gallery

Scottish referendum: we look at Scotland's Nobel drug contributions

Nobel prizes and the world’s top drug: a gallery of Scottish pharma

On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a...

Sanofi, Amgen, FDA: All change

Sanofi, Amgen, FDA: All change

Who's in, who's out: all the latest changes in senior pharmaceutical appointments.

Key Industry Events


Access all events listing

Our events, Events from partners...